Dr. Jeffrey A. Bogart says that despite evidence that twice-daily radiotherapy has positive impacts on survival, the treatment has not been routinely adopted. However, considerable uncertainty remains regarding the optimal dose of once-daily radiotherapy. Read more
Dr. Jens Vogel-Claussen says the PLCOm2012 model, which includes family history and other factors, detected 97% of lung cancer cases compared to a 77% detection rate with NELSON criteria. Read more
A multivariate analysis presented by Dr. Andrea Wolf during the World Conference on Lung Cancer shows IASLC models performed well compared to other models. However, there is room for improvement, she said. Read more
Keynote addresses from renowned investigators Dr. Drew Pardoll and Prof. Laurence Zitvogel will bookend the conference. Learn more in a Q&A with the meeting chairs. Read more
October saw two approvals from the US FDA as well as caution from the agency’s Oncologic Drug Advisory Committee regarding the interpretation of CodeBreak 200 data; Takeda announces withdrawal of mobocertinib. Read more
IASLC Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura and Drs. Valerie Rusch and Enrico Ruffini summarized the data and recommendations in lung cancer, mesothelioma, and thymic cancer. Read more
Dr. Tetsuya Mitsudomi, who presented the data at WCLC 2023, said regardless of disease stage, the addition of perioperative durvalumab did not adversely impact the feasibility, type, approach, or timing of surgery for participants in the trial. Read more
Drs. Mariam Jamal-Hanjani, Alan Sihoe, Anil Tibdewal, and Ross Soo discussed challenges and strategies across the lung cancer spectrum—from early-stage to oligometastatic and advanced disease. Read more
Honorees Drs. Jessica Donington, Rafal Dziadziuszko, and Jie Wang presented thought-provoking talks on return to treatment after surgery, radiation oncology in Poland, and biomarkers in small cell lung cancer. Read more
The IASLC Academy’s 2023 cohort spent months leading up to WCLC 2023 crafting case summaries in hopes of winning a spot in the association’s first case-based simulation course. Read more